Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-21-000337
Filing Date
2021-02-24
Accepted
2021-02-24 15:57:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A, AMENDMENT #2 a40240088a.htm SC 13G/A 39958
2 ENTITY THAT BENEFICIALLY OWNED 5% OR GREATER OF THE OUTSTANDING SHARES OF THE SE a40240088b.htm EX-99.1 1958
  Complete submission text file 0000899140-21-000337.txt   43486
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Subject) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91961 | Film No.: 21672893
SIC: 2834 Pharmaceutical Preparations

Mailing Address 140 BROADWAY, 38TH FLOOR NEW YORK NY 10005
Business Address 140 BROADWAY, 38TH FLOOR NEW YORK NY 10005 646-961-3213
Alpine Global Management, LLC (Filed by) CIK: 0001581655 (see all company filings)

EIN.: 461675291 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A